April 01, 2010, Mumbai: Karmic Lifesciences, a leading Mumbai based Contract Research Organization has appointed Dr. MV Nagendran as President – Global Medical Affairs. This announcement comes in line with another high profile appointment at Karmic India and the closure of a second round of an undisclosed investment by Basil Partners into the company.
Dr. MV Nagendran has a distinguished track record and is a Physician Cardiologist with 18 years of experience in Internal Medicine and 7 years of global experience in the Clinical Research Industry including a stint in the US. Dr. Nagendran is an MD & Gold Medalist in Internal Medicine from KMC Manipal and has earned his certification in Medical Statistics from the UK. He has 10+ international presentations in South East Asia and USA to his credit and 7 International Journal publications till date. Dr. Nagendran has managed several Pre-Clinical & Clinical projects in a wide spectrum of therapeutic areas including Cardiology, Neurology and Endocrinology and contributed across a variety of domains including trial design, protocol development, trial execution, site monitoring and data analysis. He has also served as Secretary of Ethics Committees and was earlier the Chief Operating Officer at ETI Klinical, a Bangalore based CRO.
Dr. Nagendran will be responsible for heading the Global Medical Affairs division and driving successful forays into the US, Europe, Australian and Israel markets. Given his sizeable US experience, he will also play a pivotal role in adoption of and compliance to US-FDA and ICH-GCP best practices.
Says Nidhi Saxena, Founder & CEO at Karmic Lifesciences, “Dr. Nagendran is joining the company at a critical period when we are entering an accelerated growth phase. I see his role in helping us penetrate global markets and conform to international delivery standards as invaluable. Apart from providing his medical expertise, Dr. Nagendran is a multi-faceted resource who will also render tactical guidance to the international business development teams This appointment further augments our line-up of techno-commercial professionals with deep domain expertise and global sophistication.”
About Karmic Lifesciences
Karmic Lifesciences is a one of the fastest growing, ISO 9001: 2000 certified and full-service contract research organizations based out of Mumbai, India. Karmic provides end-to-end ICH-GCP compliant clinical services including Clinical Trial Management, Clinical Data Management, Medical Writing, Biostatistics and Regulatory Submissions/Approvals and has experience of handling 50+ Phase II-IV clinical studies in multiple therapeutic areas including Oncology, Neurology, Cardiovascular, Metabolic Disorders, Immunology etc. It further has a fully US-FDA 21 CFR Part 11 compliant systems infrastructure with Clintrial 4.6, SAS 9.1.3, MedDRA 13.0 and WHODD. Its team size comprises of 40+ qualified doctors and clinical professionals and it has offices in Bangalore, Delhi and Pune besides Mumbai.
For more information or details regarding Karmic, contact sales@karmiclifesciences.com |